Cataract Surgery Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Cataract Surgery Devices Market
Cataract surgery is referred as removal of the natural lens (eye crystalline lens) that has developed an opacification. Cataract is a eye disease in which clear lens of eye becomes cloudy or opaque and causes decrease in vision. The natural lens of eye focuses light onto the retina, so images appear without distortion and clearly. The blurring of this lens during cataract formation causes distortion of vision. Cataract development is gradual and it is a process of normal ageing but occasionally can develop rapidly. Cataract generally affects both eyes, but it is uncommon for a cataract in one eye to advance more rapidly. Cataracts are very common, especially among the elder people.
Cataract surgery devices market is primarily driven by the increase in aged population, rise in the prevalence of ocular disorders, technological advancement in healthcare around the globe and economic growth in the emerging economies. However, low awareness among people about eye disorder, lack of health care insurance, and poor primary health care infrastructure in developing and under developed countries are some factors that are hindering the growth of cataract surgery devices market.
Cataract surgery devices market is segmented on the basis of type, end user, and geography
Based on the type, cataract surgery devices market is segmented as
Intraocular lenses
Ophthalmic Viscoelastic Devices
Phacoemulsification Equipment
Based on the end-user, cataract surgery devices market is segmented as:
Ophthalmology clinics
Hospitals
Ambulatory Surgical Centres
There is a significant increase in the incidence of eye diseases across the world, especially in middle-income and industrialized countries. With the high prevalence of obesity and diabetes among the young population, the risk of vision loss and other eye disorders have increased rapidly, and positively impact cataract surgery market over forecast period. People with diabetes will have increased risk of being affected by diabetic macular oedema and retinopathy. This growing prevalence of diabetic eye diseases will increase the adoption eye laser procedures, thereby positively influence the eye care surgical market in forecast period. According to National Institute of Eye, the risk of cataract will increase with each decade of life starting around the age of 40. By age 75, half of Americans and by the age of 80, 70% of the American population will have a cataract.
Geographically cataract surgery devices market is segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is the largest market for cataract surgery device market followed by Europe. The North American market for cataract surgery is high due to the surge in technological advancements in cataract devices and awareness about laser eye surgeries among key stakeholders, have boosted the sales of eye care surgical devices in the region. The growing number of laser refractive surgeries and the emergence of laser technology in treatment of cataract surgery expected to grow the market revenue. Asia Pacific region is expected to be a fastest growing cataract surgery device market due to large geriatric population.
Some of the players in cataract surgery devices market are Novartis AG (Switzerland), Carl Zeiss Meditech AG (Germany), bbott Laboratories (U.S.), Essilor International S.A. (France), Allergan, Inc. (U.S.), Opcon Corporation (Japan), NIDEK Co., Ltd. (Japan), Valeant (Bausch & Lomb)(Canada), and STAAR Surgical Company (U.S.) to name a few.
In March 2017, Alcon Inc. (a division of Novartis) received U.S. FDA approval for Multifocal Toric intraocular lens “Acrysof Iq Restor”, for the patients with astigmatic cataract patients
In June 2015, Alcon Inc. (a division of Novartis) received European CE Mark for trifocal intraocular lens “Acrysof Iq Panoptix” for the patients undergoing cataract surgery
In April 2013, Abbott Laboratories received U.S.FDA approval for “Tecnis Toric 1-Piece Intraocular Lens” and launched in United Statesfor cataract patients with pre-existing corneal astigmatism
Cataract surgery is referred as removal of the natural lens (eye crystalline lens) that has developed an opacification. Cataract is a eye disease in which clear lens of eye becomes cloudy or opaque and causes decrease in vision. The natural lens of eye focuses light onto the retina, so images appear without distortion and clearly. The blurring of this lens during cataract formation causes distortion of vision. Cataract development is gradual and it is a process of normal ageing but occasionally can develop rapidly. Cataract generally affects both eyes, but it is uncommon for a cataract in one eye to advance more rapidly. Cataracts are very common, especially among the elder people.
Cataract surgery devices market is primarily driven by the increase in aged population, rise in the prevalence of ocular disorders, technological advancement in healthcare around the globe and economic growth in the emerging economies. However, low awareness among people about eye disorder, lack of health care insurance, and poor primary health care infrastructure in developing and under developed countries are some factors that are hindering the growth of cataract surgery devices market.
Cataract surgery devices market is segmented on the basis of type, end user, and geography
Based on the type, cataract surgery devices market is segmented as
Intraocular lenses
Ophthalmic Viscoelastic Devices
Phacoemulsification Equipment
Based on the end-user, cataract surgery devices market is segmented as:
Ophthalmology clinics
Hospitals
Ambulatory Surgical Centres
There is a significant increase in the incidence of eye diseases across the world, especially in middle-income and industrialized countries. With the high prevalence of obesity and diabetes among the young population, the risk of vision loss and other eye disorders have increased rapidly, and positively impact cataract surgery market over forecast period. People with diabetes will have increased risk of being affected by diabetic macular oedema and retinopathy. This growing prevalence of diabetic eye diseases will increase the adoption eye laser procedures, thereby positively influence the eye care surgical market in forecast period. According to National Institute of Eye, the risk of cataract will increase with each decade of life starting around the age of 40. By age 75, half of Americans and by the age of 80, 70% of the American population will have a cataract.
Geographically cataract surgery devices market is segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is the largest market for cataract surgery device market followed by Europe. The North American market for cataract surgery is high due to the surge in technological advancements in cataract devices and awareness about laser eye surgeries among key stakeholders, have boosted the sales of eye care surgical devices in the region. The growing number of laser refractive surgeries and the emergence of laser technology in treatment of cataract surgery expected to grow the market revenue. Asia Pacific region is expected to be a fastest growing cataract surgery device market due to large geriatric population.
Some of the players in cataract surgery devices market are Novartis AG (Switzerland), Carl Zeiss Meditech AG (Germany), bbott Laboratories (U.S.), Essilor International S.A. (France), Allergan, Inc. (U.S.), Opcon Corporation (Japan), NIDEK Co., Ltd. (Japan), Valeant (Bausch & Lomb)(Canada), and STAAR Surgical Company (U.S.) to name a few.
In March 2017, Alcon Inc. (a division of Novartis) received U.S. FDA approval for Multifocal Toric intraocular lens “Acrysof Iq Restor”, for the patients with astigmatic cataract patients
In June 2015, Alcon Inc. (a division of Novartis) received European CE Mark for trifocal intraocular lens “Acrysof Iq Panoptix” for the patients undergoing cataract surgery
In April 2013, Abbott Laboratories received U.S.FDA approval for “Tecnis Toric 1-Piece Intraocular Lens” and launched in United Statesfor cataract patients with pre-existing corneal astigmatism
1. EXECUTIVE SUMMARY
2. GLOBAL CATARACT SURGERY DEVICES MARKET INTRODUCTION
2.1. Global Cataract Surgery Devices Market – Taxonomy
2.2. Global Cataract Surgery Devices Market –Definitions
2.2.1. Type
2.2.2. End User
3. GLOBAL CATARACT SURGERY DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cataract Surgery Devices Market Dynamic Factors - Impact Analysis
3.6. Global Cataract Surgery Devices Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Cataract Surgery Devices Market –Trends
4. GLOBAL CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL CATARACT SURGERY DEVICES MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Intraocular lenses
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Ophthalmic Viscoelastic Devices
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Phacoemulsification Equipment
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. GLOBAL CATARACT SURGERY DEVICES MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Ophthalmology clinics
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Hospitals
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Ambulatory Surgical Centres
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. GLOBAL CATARACT SURGERY DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
7.1. North America
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Region, 2017 – 2023
8. NORTH AMERICA CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Intraocular lenses
8.1.2. Ophthalmic Viscoelastic Devices
8.1.3. Phacoemulsification Equipment
8.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Ophthalmology clinics
8.2.2. Hospitals
8.2.3. Ambulatory Surgical Centres
8.3. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
8.5. North America Cataract Surgery Devices Market Dynamics – Trends
9. EUROPE CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Intraocular lenses
9.1.2. Ophthalmic Viscoelastic Devices
9.1.3. Phacoemulsification Equipment
9.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Ophthalmology clinics
9.2.2. Hospitals
9.2.3. Ambulatory Surgical Centres
9.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
9.5. Europe Cataract Surgery Devices Market Dynamics – Trends
10. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Intraocular lenses
10.1.2. Ophthalmic Viscoelastic Devices
10.1.3. Phacoemulsification Equipment
10.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Ophthalmology clinics
10.2.2. Hospitals
10.2.3. Ambulatory Surgical Centres
10.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
10.5. Asia-Pacific Cataract Surgery Devices Market Dynamics – Trends
11. LATIN AMERICA CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Intraocular lenses
11.1.2. Ophthalmic Viscoelastic Devices
11.1.3. Phacoemulsification Equipment
11.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Ophthalmology clinics
11.2.2. Hospitals
11.2.3. Ambulatory Surgical Centres
11.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
11.5. Latin America Cataract Surgery Devices Market Dynamics – Trends
12. MIDDLE EAST AND AFRICA CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Intraocular lenses
12.1.2. Ophthalmic Viscoelastic Devices
12.1.3. Phacoemulsification Equipment
12.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Ophthalmology clinics
12.2.2. Hospitals
12.2.3. Ambulatory Surgical Centres
12.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
12.5. MEA Cataract Surgery Devices Market Dynamics – Trends
13. COMPETITION LANDSCAPE
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Abbott Laboratories (U.S)
13.2.2. Boston Scientific Corporation (U.S)
13.2.3. Maquet (Germany)
13.2.4. Medtronic (U.S)
13.2.5. LivaNova PLC. (U.K)
13.2.6. Terumo Medical Corporation (Japan)
13.2.7. Johnson & Johnson Services Inc., (US)
13.2.8. Biotronik (Germany)
13.2.9. Cordis Corporation (U.S)
14. RESEARCH METHODOLOGY
15. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL CATARACT SURGERY DEVICES MARKET INTRODUCTION
2.1. Global Cataract Surgery Devices Market – Taxonomy
2.2. Global Cataract Surgery Devices Market –Definitions
2.2.1. Type
2.2.2. End User
3. GLOBAL CATARACT SURGERY DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cataract Surgery Devices Market Dynamic Factors - Impact Analysis
3.6. Global Cataract Surgery Devices Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Cataract Surgery Devices Market –Trends
4. GLOBAL CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL CATARACT SURGERY DEVICES MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Intraocular lenses
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Ophthalmic Viscoelastic Devices
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Phacoemulsification Equipment
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. GLOBAL CATARACT SURGERY DEVICES MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Ophthalmology clinics
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Hospitals
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Ambulatory Surgical Centres
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. GLOBAL CATARACT SURGERY DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
7.1. North America
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Region, 2017 – 2023
8. NORTH AMERICA CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Intraocular lenses
8.1.2. Ophthalmic Viscoelastic Devices
8.1.3. Phacoemulsification Equipment
8.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Ophthalmology clinics
8.2.2. Hospitals
8.2.3. Ambulatory Surgical Centres
8.3. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
8.5. North America Cataract Surgery Devices Market Dynamics – Trends
9. EUROPE CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Intraocular lenses
9.1.2. Ophthalmic Viscoelastic Devices
9.1.3. Phacoemulsification Equipment
9.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Ophthalmology clinics
9.2.2. Hospitals
9.2.3. Ambulatory Surgical Centres
9.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
9.5. Europe Cataract Surgery Devices Market Dynamics – Trends
10. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Intraocular lenses
10.1.2. Ophthalmic Viscoelastic Devices
10.1.3. Phacoemulsification Equipment
10.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Ophthalmology clinics
10.2.2. Hospitals
10.2.3. Ambulatory Surgical Centres
10.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
10.5. Asia-Pacific Cataract Surgery Devices Market Dynamics – Trends
11. LATIN AMERICA CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Intraocular lenses
11.1.2. Ophthalmic Viscoelastic Devices
11.1.3. Phacoemulsification Equipment
11.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Ophthalmology clinics
11.2.2. Hospitals
11.2.3. Ambulatory Surgical Centres
11.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
11.5. Latin America Cataract Surgery Devices Market Dynamics – Trends
12. MIDDLE EAST AND AFRICA CATARACT SURGERY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Intraocular lenses
12.1.2. Ophthalmic Viscoelastic Devices
12.1.3. Phacoemulsification Equipment
12.2. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Ophthalmology clinics
12.2.2. Hospitals
12.2.3. Ambulatory Surgical Centres
12.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Cataract Surgery Devices Market - Opportunity Analysis Index, By Product, By End Use and Country, 2017 – 2023
12.5. MEA Cataract Surgery Devices Market Dynamics – Trends
13. COMPETITION LANDSCAPE
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Abbott Laboratories (U.S)
13.2.2. Boston Scientific Corporation (U.S)
13.2.3. Maquet (Germany)
13.2.4. Medtronic (U.S)
13.2.5. LivaNova PLC. (U.K)
13.2.6. Terumo Medical Corporation (Japan)
13.2.7. Johnson & Johnson Services Inc., (US)
13.2.8. Biotronik (Germany)
13.2.9. Cordis Corporation (U.S)
14. RESEARCH METHODOLOGY
15. KEY ASSUMPTIONS AND ACRONYMS
